Yorktown Management & Research Company’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,800
Closed -$273K 211
2025
Q2
$273K Hold
1,800
0.26% 178
2025
Q1
$271K Hold
1,800
0.29% 166
2024
Q4
$332K Hold
1,800
0.32% 156
2024
Q3
$355K Hold
1,800
0.36% 137
2024
Q2
$372K Hold
1,800
0.4% 107
2024
Q1
$488K Hold
1,800
0.46% 69
2023
Q4
$426K Hold
1,800
0.44% 86
2023
Q3
$353K Hold
1,800
0.4% 103
2023
Q2
$378K Hold
1,800
0.41% 111
2023
Q1
$363K Hold
1,800
0.39% 101
2022
Q4
$392K Hold
1,800
0.48% 88
2022
Q3
$354K Hold
1,800
0.46% 80
2022
Q2
$385K Hold
1,800
0.5% 86
2022
Q1
$511K Hold
1,800
0.43% 94
2021
Q4
$678K Hold
1,800
0.46% 61
2021
Q3
$743K Hold
1,800
0.56% 37
2021
Q2
$666K Hold
1,800
0.52% 41
2021
Q1
$522K Hold
1,800
0.43% 68
2020
Q4
$450K Hold
1,800
0.4% 104
2020
Q3
$408K Sell
1,800
-1,700
-49% -$353K 0.38% 99
2020
Q2
$610K Buy
3,500
+1,700
+94% +$271K 0.55% 23
2020
Q1
$227K Buy
+1,800
New +$270K 0.23% 191
2018
Q4
Sell
-3,000
Closed -$404K 324
2018
Q3
$404K Hold
3,000
0.12% 182
2018
Q2
$337K Hold
3,000
0.1% 230
2018
Q1
$320K Buy
+3,000
New +$323K 0.09% 239

Other funds holding CRL

Yorktown Management & Research Company's CRL Position: Q3 2025 in Review

Yorktown Management & Research Company sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 1,800 shares — an estimated $273K sold.

Yorktown Management & Research Company first reported a position in CRL in Q1 2018 and held it in 25 quarters. The position peaked at $743K in Q3 2021. 554 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Yorktown Management & Research Company reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Yorktown Management & Research Company sold 1,800 Charles River Laboratories shares in Q3 2025, an estimated $273K.
  • Yorktown Management & Research Company first reported a position in Charles River Laboratories in Q1 2018 and held it in 25 quarters.
  • Yorktown Management & Research Company's Charles River Laboratories position peaked at $743K in Q3 2021.
  • 554 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Yorktown Management & Research Company's 13F filing for Q3 2025, filed 29 Oct 2025.